Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1996-9-26
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0006-3223
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
39
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1-4
|
pubmed:dateRevised |
2005-11-16
|
pubmed:meshHeading |
pubmed-meshheading:8719118-Antipsychotic Agents,
pubmed-meshheading:8719118-Catatonia,
pubmed-meshheading:8719118-Diagnosis, Differential,
pubmed-meshheading:8719118-Humans,
pubmed-meshheading:8719118-Neuroleptic Malignant Syndrome,
pubmed-meshheading:8719118-Neurologic Examination,
pubmed-meshheading:8719118-Syndrome
|
pubmed:year |
1996
|
pubmed:articleTitle |
Neuroleptic malignant syndrome and catatonia: one entity or two?
|
pubmed:publicationType |
Editorial,
Review
|